Santalis Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2010-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
5
Active:0
Completed:3
Trial Phases
1 Phases
Phase 2:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 2
5 (100.0%)A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
Phase 2
Withdrawn
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: PlaceboDrug: SAN007 Cream
- First Posted Date
- 2016-12-22
- Last Posted Date
- 2019-01-17
- Lead Sponsor
- Santalis Pharmaceuticals, Inc.
- Registration Number
- NCT03000595
A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis
Phase 2
Completed
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: SAN021 PlaceboDrug: SAN021 Serum
- First Posted Date
- 2016-12-22
- Last Posted Date
- 2019-05-29
- Lead Sponsor
- Santalis Pharmaceuticals, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT03000608
- Locations
- 🇺🇸
DermResearch, Inc., Austin, Texas, United States
🇺🇸Progressive Clinical Research, San Antonio, Texas, United States
🇺🇸Clinical Trial of Texas, San Antonio, Texas, United States
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults
Phase 2
Withdrawn
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: SAN021 SerumDrug: SAN021 Placebo
- First Posted Date
- 2016-12-15
- Last Posted Date
- 2019-01-17
- Lead Sponsor
- Santalis Pharmaceuticals, Inc.
- Registration Number
- NCT02993328
- Locations
- 🇦🇺
Dermatology West, Fremantle, Western Australia, Australia
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
Phase 2
Completed
- Conditions
- Atopic DermatitisEczema
- Interventions
- Drug: PlaceboDrug: SAN007 10% creamDrug: SAN007 5% cream
- First Posted Date
- 2016-08-18
- Last Posted Date
- 2019-05-29
- Lead Sponsor
- Santalis Pharmaceuticals, Inc.
- Target Recruit Count
- 71
- Registration Number
- NCT02871479
- Locations
- 🇺🇸
DermResearch, Austin, Texas, United States
🇺🇸J&S Sudies Pharmaceutical, Bryan, Texas, United States
🇺🇸Progressive Clinical Research, San Antonio, Texas, United States
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Oral Mucositis
Phase 2
Completed
- Conditions
- Oral Mucositis
- Interventions
- Drug: 0.25% EISO mouth rinse
- First Posted Date
- 2015-03-26
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- Santalis Pharmaceuticals, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT02399228
- Locations
- 🇺🇸
UTHSCSA Cancer Therapy and Research Center (CTRC), San Antonio, Texas, United States
News
No news found